相关实验视频
Updated: Jan 9, 2026
10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.8K
失调的circRNA-miRNA-mRNA网络揭示了帕金森病的特定阶段mRNA表达变化
Yulan Gao1, Konii Takenaka1, Kristina Santucci1
1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Molecular brain
|December 2, 2025
概括
这项研究揭示了帕金森病 (PD) 进展中的新型循环RNA (circRNA) 和微RNA (miRNA) 相互作用. 像circPRDM2和circHSH2D这样的特定circRNA可以作为这种神经退行性疾病的关键生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 帕金森病 (PD) 涉及多巴胺基神经元损失和转录基因变化.
- 非编码RNAs,特别是循环RNAs (circRNAs) 和microRNAs (miRNAs),越来越多地被认为是它们在PD中的调节作用.
- circRNAs可以作为竞争的内源RNAs (ceRNAs) 起作用,通过与miRNAs相互作用来影响基因表达.
研究的目的:
- 在四个PD阶段动态分析转录组数据,以确定关键的circRNA-miRNA-mRNA网络.
- 构建特定阶段的ceRNA网络并确定参与PD病变发生的独特circRNA.
- 为了研究PD中由circRNAs调节的目标基因的编码潜力.
主要方法:
- RNA测序 (RNA-seq) 用于在不同PD阶段进行动态转录组分析.
- 特定阶段的ceRNA网络是通过识别共同调节的circRNA和线性转录来构建的.
- 确定了具有预测ceRNA活性的差异表达circRNA,包括circPRDM2和circHSH2D.
主要成果:
- 在帕金森病中发现了新的特定阶段的circRNA-miRNA-mRNA网络.
- 在PD患者中,circPRDM2和circHSH2D被发现具有上调和独特的表达,表现出预测的ceRNA活性.
- 该研究评估了目标基因的编码潜力,提供了对circRNA调节影响的见解.
结论:
- 这项研究阐明了PD的转录后调节机制,突出了circRNA-miRNA-mRNA相互作用的作用.
- 已确定特定阶段的ceRNA轴,包括circPRDM2和circHSH2D,代表了帕金森病的潜在生物标志物或治疗点.
相关概念视频
01:37Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
01:22MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
01:22MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:24Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945